OMass Therapeutics (‘OMass’ or ‘the Company’), a biotechnology company identifying medicines against highly validated target ecosystems such as membrane proteins or intracellular complexes, today ...

Sickle Cell Disease Treatment Market is estimated to be valued at USD 3.20 Bn in 2025 and is expected to reach USD 8.81 Bn by 2032 exhibiting a CAGR of 15.6% Mr. Shah Coherent Market Insights Pvt. Ltd ...

Apple shareholders on February 25 voted to keep the tech giant's diversity, equity and inclusion (DEI) policies, a win for ...

NEW DELHI – U.S. drugmaker Amgen plans to invest approximately $200 million this year in its new technology center located in ...

Telangana Chief Minister A Revanth Reddy said that he wanted to transform the state's economy into a trillion-dollar economy in the next 10 years. He participated in the inauguration of the "Bio Asia ...

US biotech major Amgen will invest about $200 million this year in its new technology center in southern India.

The first day of the BioAsia 2025 conference witnessed a major boost for Telangana in terms of the number of investments and ...

Hyderabad: The 22nd edition of BioAsia 2025, Asia’s largest life sciences and healthcare conference, was inaugurated by Chief ...

US drugmaker Amgen will invest about $200 million this year in its new technology centre in southern India, with further ...

Amgen opens new technology and innovation site in Hyderabad, to invest $200 million through 2025: Our Bureau, Bengaluru ...

EconoTimes is a global, independent publication that delivers comprehensive news, analysis, and insights on the economy, finance, and markets. Based in Korea, we offer a unique perspective on global ...

The company plans to invest USD 200 million through 2025, with additional sustained investments planned over the coming years ...